• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4例马罗-拉米综合征患者的心脏瓣膜病

Valvular heart disease in four patients with Maroteaux-Lamy syndrome.

作者信息

Tan C T, Schaff H V, Miller F A, Edwards W D, Karnes P S

机构信息

Section of Thoracic and Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905.

出版信息

Circulation. 1992 Jan;85(1):188-95. doi: 10.1161/01.cir.85.1.188.

DOI:10.1161/01.cir.85.1.188
PMID:1728449
Abstract

BACKGROUND

Maroteaux-Lamy syndrome is a lysosomal storage disease of mucopolysaccharide metabolism (MPS type VI) that may involve the mitral and aortic valves. Affected patients have other skeletal and oropharyngeal malformations that complicate anesthetic and surgical management.

METHODS AND RESULTS

The present report describes the clinical, echocardiographic, and pathological findings in four patients with Maroteaux-Lamy syndrome. Two of three siblings underwent successful double-valve replacement for aortic and mitral valve stenoses. The third sibling, whose aortic and mitral valves were thick and fibrotic, died from septicemia after hip surgery. A fourth, unrelated patient also had successful double-valve replacement.

CONCLUSIONS

Our experience emphasizes the potential difficulties in preoperative assessment and surgical treatment as well as the unique problems related to airway management in patients with this syndrome.

摘要

背景

马罗-拉米综合征是一种黏多糖代谢的溶酶体贮积病(Ⅵ型黏多糖贮积症),可能累及二尖瓣和主动脉瓣。受影响的患者还存在其他骨骼和口咽畸形,这使麻醉和手术管理变得复杂。

方法与结果

本报告描述了4例马罗-拉米综合征患者的临床、超声心动图和病理检查结果。三兄妹中的两人因主动脉瓣和二尖瓣狭窄成功接受了双瓣置换术。第三个兄妹的主动脉瓣和二尖瓣增厚且纤维化,在髋关节手术后死于败血症。第四例非亲属患者也成功接受了双瓣置换术。

结论

我们的经验强调了该综合征患者术前评估和手术治疗的潜在困难,以及与气道管理相关的独特问题。

相似文献

1
Valvular heart disease in four patients with Maroteaux-Lamy syndrome.4例马罗-拉米综合征患者的心脏瓣膜病
Circulation. 1992 Jan;85(1):188-95. doi: 10.1161/01.cir.85.1.188.
2
Mitral stenosis in the Maroteaux-Lamy syndrome: a treatable cause of dyspnoea.马罗-拉米综合征中的二尖瓣狭窄:一种可治疗的呼吸困难病因。
Postgrad Med J. 1992 Apr;68(798):287-8. doi: 10.1136/pgmj.68.798.287.
3
Maroteaux-Lamy syndrome: a rare and challenging case of mitral valve replacement.马罗-拉米综合征:二尖瓣置换术的一例罕见且具有挑战性的病例。
Asian Cardiovasc Thorac Ann. 2018 Sep;26(7):560-562. doi: 10.1177/0218492316675533. Epub 2016 Oct 18.
4
Double valve replacement in a patient with Maroteaux - Lamy syndrome as an ultimate team challenge.马罗托-拉米综合征患者的双瓣膜置换术:终极团队挑战。
J Cardiothorac Surg. 2021 May 24;16(1):141. doi: 10.1186/s13019-021-01530-x.
5
Combined aortic and mitral valve replacement in an adult with mucopolysaccharidosis (Maroteaux-Lamy syndrome).一名患有黏多糖贮积症(马罗-拉米综合征)的成年人接受主动脉瓣和二尖瓣联合置换术。
Heart Vessels. 1996;11(4):215-7. doi: 10.1007/BF02559995.
6
Aortic and Mitral Valve Involvement in Maroteaux-Lamy Syndrome VI: Surgical Implications in the Enzyme Replacement Therapy Era.马罗-拉米综合征VI中的主动脉瓣和二尖瓣受累:酶替代治疗时代的手术意义
Ann Thorac Surg. 2016 Jul;102(1):e23-5. doi: 10.1016/j.athoracsur.2015.11.062.
7
Combined valve replacement and aortocoronary bypass in an adult mucopolysaccharidosis type VII patient.在一名成年黏多糖贮积症 VII 型患者中进行联合瓣膜置换和主动脉冠状动脉旁路移植术。
Cardiovasc Pathol. 2021 Jan-Feb;50:107297. doi: 10.1016/j.carpath.2020.107297. Epub 2020 Oct 9.
8
Combined aortic and mitral stenosis in mucopolysaccharidosis type I-S (Ullrich-Scheie syndrome).I-S型黏多糖贮积症(乌尔里希-谢伊综合征)合并主动脉瓣和二尖瓣狭窄。
Heart. 1999 Jan;81(1):97-9. doi: 10.1136/hrt.81.1.97.
9
Double-valve replacement for Scheie's syndrome subtype mucopolysaccaridosis type 1-S.Scheie 综合征亚型黏多糖贮积症 1-S 行双瓣置换术。
Ann Thorac Surg. 2011 Sep;92(3):1104-5. doi: 10.1016/j.athoracsur.2011.03.051.
10
Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome).巨噬细胞在黏多糖贮积症 VI 型(马罗托克斯-拉米综合征)二尖瓣病变中的作用。
Am J Med Genet A. 2013 Oct;161A(10):2550-3. doi: 10.1002/ajmg.a.36105. Epub 2013 Aug 15.

引用本文的文献

1
Metabolic Cardiomyopathies and Cardiac Defects in Inherited Disorders of Carbohydrate Metabolism: A Systematic Review.遗传性碳水化合物代谢紊乱相关的代谢性心肌病和心脏缺陷:系统综述。
Int J Mol Sci. 2023 May 11;24(10):8632. doi: 10.3390/ijms24108632.
2
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.计划进行心脏介入治疗的成年黏多糖贮积症患者的术前注意事项。
Front Cardiovasc Med. 2022 Apr 4;9:851016. doi: 10.3389/fcvm.2022.851016. eCollection 2022.
3
Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.
黏多糖贮积症中瓣膜性心脏病的外科治疗:文献综述
Biomedicines. 2022 Feb 4;10(2):375. doi: 10.3390/biomedicines10020375.
4
Double valve replacement in a patient with Maroteaux - Lamy syndrome as an ultimate team challenge.马罗托-拉米综合征患者的双瓣膜置换术:终极团队挑战。
J Cardiothorac Surg. 2021 May 24;16(1):141. doi: 10.1186/s13019-021-01530-x.
5
Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.黏多糖贮积症 I 型:自然病史和分子病理学综述。
Cells. 2020 Aug 5;9(8):1838. doi: 10.3390/cells9081838.
6
Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.黏多糖贮积症 VI 型:一例以胎儿腹水和快速进展性心脏表现为首发表现的新生儿病例报告。
BMC Med Genet. 2020 Feb 19;21(1):37. doi: 10.1186/s12881-020-0972-y.
7
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.MPS VI 管理建议:基于系统证据和共识的指南。
Orphanet J Rare Dis. 2019 May 29;14(1):118. doi: 10.1186/s13023-019-1080-y.
8
Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.黏多糖贮积症患者的主动脉根部扩张及酶替代疗法的影响。
Heart Vessels. 2019 Feb;34(2):290-295. doi: 10.1007/s00380-018-1242-1. Epub 2018 Aug 22.
9
Mucopolysaccharidosis VI: cardiac involvement and the impact of enzyme replacement therapy.黏多糖贮积症VI型:心脏受累及酶替代疗法的影响
J Inherit Metab Dis. 2014 Mar;37(2):269-76. doi: 10.1007/s10545-013-9649-4. Epub 2013 Sep 24.
10
Current and emerging management options for patients with Morquio A syndrome.黏多糖贮积症 A 型患者的现行和新兴治疗选择。
Ther Clin Risk Manag. 2013;9:45-53. doi: 10.2147/TCRM.S24771. Epub 2013 Feb 11.